47 related articles for article (PubMed ID: 36080457)
21. Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer.
Yang XH; Li KG; Wei JB; Wu CH; Liang SX; Mo XW; Chen JS; Tang WZ; Qu S
Sci Rep; 2020 Jul; 10(1):12539. PubMed ID: 32719436
[TBL] [Abstract][Full Text] [Related]
22. Formulation, Characterization and
Patel P; Barot T; Kulkarni P
Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of Polymeric Microparticles by Electrospray: The Impact of Experimental Parameters.
Morais AÍS; Vieira EG; Afewerki S; Sousa RB; Honorio LMC; Cambrussi ANCO; Santos JA; Bezerra RDS; Furtini JAO; Silva-Filho EC; Webster TJ; Lobo AO
J Funct Biomater; 2020 Jan; 11(1):. PubMed ID: 31952157
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-loaded polysaccharides-based complex particles obtained by polyelectrolyte complexation and ionic gelation. I-Particles obtaining and characterization.
Iurciuc-Tincu CE; Atanase LI; Ochiuz L; Jérôme C; Sol V; Martin P; Popa M
Int J Biol Macromol; 2020 Mar; 147():629-642. PubMed ID: 31904456
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer.
Dekker E; Tanis PJ; Vleugels JLA; Kasi PM; Wallace MB
Lancet; 2019 Oct; 394(10207):1467-1480. PubMed ID: 31631858
[TBL] [Abstract][Full Text] [Related]
26. Targets for improving tumor response to radiotherapy.
Mortezaee K; Parwaie W; Motevaseli E; Mirtavoos-Mahyari H; Musa AE; Shabeeb D; Esmaely F; Najafi M; Farhood B
Int Immunopharmacol; 2019 Nov; 76():105847. PubMed ID: 31466051
[TBL] [Abstract][Full Text] [Related]
27. MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling.
Jin P; Jiang J; Xie N; Zhou L; Huang Z; Zhang L; Qin S; Fu S; Peng L; Gao W; Li B; Lei Y; Nice EC; Li C; Shao J; Xie K
Cell Death Dis; 2019 Aug; 10(8):615. PubMed ID: 31409796
[TBL] [Abstract][Full Text] [Related]
28. Coaxial Electrohydrodynamic Atomization for the Production of Drug-Loaded Micro/Nanoparticles.
Chen C; Liu W; Jiang P; Hong T
Micromachines (Basel); 2019 Feb; 10(2):. PubMed ID: 30769856
[TBL] [Abstract][Full Text] [Related]
29. Electrospraying an enabling technology for pharmaceutical and biomedical applications: A review.
Boda SK; Li X; Xie J
J Aerosol Sci; 2018 Nov; 125():164-181. PubMed ID: 30662086
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy with melatonin for targeting human cancers: A review.
Najafi M; Salehi E; Farhood B; Nashtaei MS; Hashemi Goradel N; Khanlarkhani N; Namjoo Z; Mortezaee K
J Cell Physiol; 2019 Mar; 234(3):2356-2372. PubMed ID: 30192001
[TBL] [Abstract][Full Text] [Related]
31. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.
Yu DG; Li JJ; Williams GR; Zhao M
J Control Release; 2018 Dec; 292():91-110. PubMed ID: 30118788
[TBL] [Abstract][Full Text] [Related]
32. Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.
Dudhipala N; Puchchakayala G
Drug Dev Ind Pharm; 2018 Oct; 44(10):1572-1582. PubMed ID: 29493289
[TBL] [Abstract][Full Text] [Related]
33. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives.
Banerjee A; Pathak S; Subramanium VD; G D; Murugesan R; Verma RS
Drug Discov Today; 2017 Aug; 22(8):1224-1232. PubMed ID: 28545838
[TBL] [Abstract][Full Text] [Related]
34. Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation.
Gad HA; Kamel AO; Ezzat OM; El Dessouky HF; Sammour OA
Expert Opin Drug Deliv; 2017 Nov; 14(11):1241-1251. PubMed ID: 28485988
[TBL] [Abstract][Full Text] [Related]
35. Osimertinib effective in EGFR T790M-positive lung cancer.
Mayor S
Lancet Oncol; 2017 Jan; 18(1):e9. PubMed ID: 27989430
[No Abstract] [Full Text] [Related]
36. Par3L enhances colorectal cancer cell survival by inhibiting Lkb1/AMPK signaling pathway.
Li T; Liu D; Lei X; Jiang Q
Biochem Biophys Res Commun; 2017 Jan; 482(4):1037-1041. PubMed ID: 27908725
[TBL] [Abstract][Full Text] [Related]
37. The role of pharmacogenetics in capecitabine efficacy and toxicity.
Lam SW; Guchelaar HJ; Boven E
Cancer Treat Rev; 2016 Nov; 50():9-22. PubMed ID: 27569869
[TBL] [Abstract][Full Text] [Related]
38. Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo.
Chen Z; Chen Y; Xu M; Chen L; Zhang X; To KK; Zhao H; Wang F; Xia Z; Chen X; Fu L
Mol Cancer Ther; 2016 Aug; 15(8):1845-58. PubMed ID: 27196753
[TBL] [Abstract][Full Text] [Related]
39. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.
Zhang N; Fu JN; Chou TC
Am J Cancer Res; 2016; 6(1):97-104. PubMed ID: 27073727
[TBL] [Abstract][Full Text] [Related]
40. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]